PMID- 28740001
OWN - NLM
STAT- MEDLINE
DCOM- 20171208
LR  - 20171208
IS  - 1881-6096 (Print)
IS  - 1881-6096 (Linking)
VI  - 69
IP  - 7
DP  - 2017 Jul
TI  - [Alzheimer's Therapeutic Research Institute].
PG  - 856-861
LID - 10.11477/mf.1416200831 [doi]
AB  - The Alzheimer's Therapeutic Research Institute (ATRI) was established in 2015 
      after ATRI director, Paul Aisen, and his fellow experts in therapeutic 
      interventions for Alzheimer's disease (AD) moved from the Alzheimer's Disease 
      Cooperative Study (ADCS) at the University of California to the Keck School of 
      Medicine of the University of Southern California. The National Institute on 
      Aging (NIA) decided to commit $14 million to the ATRI via an Alzheimer's Clinical 
      Trials Consortium (ACTC). The ATRI supports various studies such as the 
      Anti-Amyloid Treatment in Asymptomatic Alzheimer's study ("A4 study"), 
      Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3), Longitudinal Evaluation of 
      Amyloid Risk and Neurodegeneration (LEARN), and The Alzheimer's Disease 
      Neuroimaging Initiative-Depression Project (ADNI-D). The ATRI will share all 
      relevant data and materials with the academic community, corporations, and 
      government organizations. The ATRI is overseen by a Data and Safety Monitoring 
      Board (DSMB), which comprises of leading experts in the field of Alzheimer's 
      research and acts independently. The ATRI is slated to play a central role in 
      clinical dementia research in the US in near future.
FAU - Shimada, Hiroyuki
AU  - Shimada H
AD  - Clinical Research Center for Dementia, Graduate School of Medicine, Osaka City 
      University.
FAU - Kato, Yuichi
AU  - Kato Y
FAU - Fujii, Hisako
AU  - Fujii H
FAU - Mori, Hiroshi
AU  - Mori H
LA  - jpn
PT  - Journal Article
PT  - Review
PL  - Japan
TA  - Brain Nerve
JT  - Brain and nerve = Shinkei kenkyu no shinpo
JID - 101299709
RN  - 0 (Biomarkers)
SB  - IM
MH  - *Academies and Institutes
MH  - *Alzheimer Disease
MH  - Biomarkers/analysis
MH  - Clinical Trials as Topic
MH  - Humans
MH  - United States
EDAT- 2017/07/26 06:00
MHDA- 2017/12/09 06:00
CRDT- 2017/07/26 06:00
PHST- 2017/07/26 06:00 [entrez]
PHST- 2017/07/26 06:00 [pubmed]
PHST- 2017/12/09 06:00 [medline]
AID - 1416200831 [pii]
AID - 10.11477/mf.1416200831 [doi]
PST - ppublish
SO  - Brain Nerve. 2017 Jul;69(7):856-861. doi: 10.11477/mf.1416200831.